Skip to content

Biogen BIIB Short-Term Investments

Short-Term Investments at other companies

Rogers Corporation logo
Rogers CorporationROG
$30M
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$569.25M+22.7%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$37.99M-84.3%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$221.17M-38.3%
Regenxbio logo
RegenxbioRGNX
$135.26M-1.8%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$83.58M-13.2%

Other financials

Income statement

See full
Revenue$2.7B+3.4%
Gross profit$2.0B-4.0%
Operating income$610.7M
Net income$97.5M-84.6%
EPS (diluted)$0.66-84.8%

Balance sheet

See full
Cash & equivalents$1.3B-53.4%
Total debt$7.6B+14.6%
Total equity$18.8B+6.9%
Total assets$32.1B+13.3%

Cash flow

See full
Operating cash flow$448.9M+179%
CapEx$40.9M+53.8%
Free cash flow$408.0M+204%

Valuation

See full
Market cap$30.36B+62.0%
Enterprise value$36.63B+62.2%
P/E34.4×+22.1×
P/S+1.2×

Profitability

See full
Gross margin74%-1.4pp
Operating margin22.9%
Net margin8.8%-6.5pp
FCF margin26.9%+7.1pp

Returns & leverage

See full
Return on equity4.8%-4.3pp
Debt / equity0.4×0.0×
Current ratio1.9×-0.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Biogen’s 10-Q, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's short-term investments?
Biogen (BIIB) reported short-term investments of $0 in Q2 2026.
What is the long-term trend for Biogen's short-term investments?
Over 5 years (2020 to 2025), Biogen's short-term investments has grown at a -8.8% compound annual growth rate (CAGR), from $1.28B to $807.2M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.